Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

False-positives in spontaneous reporting: should we worry about them?

B Begaud1, Y Moride, P Tubert-Bitter

  • 1Département de Pharmacologie, Université de Bordeaux II, Hôpital Pellegrin, France.

British Journal of Clinical Pharmacology
|November 1, 1994
PubMed
Summary

Spontaneous reporting is key for identifying adverse drug reactions (ADRs). A new method shows that coincidental reports are unlikely, especially for rare events, strengthening the value of this pharmacovigilance approach.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early exposure of pregnant women to non-steroidal anti-inflammatory drugs delivered outside hospitals and preterm birth risk: nationwide cohort study.

BJOG : an international journal of obstetrics and gynaecology·2021
Same author

[Use and misuse of benzodiazepines out of France].

Presse medicale (Paris, France : 1983)·2018
Same author

Acute Methiopropamine Intoxication After "Synthacaine" Consumption.

Journal of analytical toxicology·2016
Same author

Risk assessment of drug-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a disproportionality analysis using the French Pharmacovigilance Database.

The British journal of dermatology·2016
Same author

A new self-controlled case series method for analyzing spontaneous reports of adverse events after vaccination.

American journal of epidemiology·2013
Same author

[Exception drugs status: specific characteristics and the role in the proper use of drugs].

Revue d'epidemiologie et de sante publique·2013

Area of Science:

  • Pharmacovigilance and Drug Safety
  • Biostatistics
  • Epidemiology

Background:

  • Spontaneous reporting systems are the primary method for detecting adverse drug reactions (ADRs).
  • A significant limitation, false-positive reports due to coincidental drug-event associations, has been under-examined.
  • Assessing the reliability of spontaneous ADR reports is crucial for drug safety.

Observation:

  • A novel method utilizing the Poisson distribution was developed to calculate the maximum expected coincidental reports for a given adverse drug reaction (ADR).
  • This calculation requires three key parameters: background event risk, total patient exposure to the drug, and reporting proportion to the pharmacovigilance system.
  • The expected number of coincidental reports is generally low in post-marketing surveillance, typically one to three cases.

Related Experiment Videos

Findings:

  • For common adverse events, a small number of reports (1-3) may represent coincidental associations.
  • For rare adverse events like agranulocytosis or toxic epidermal necrolysis, more than three reports strongly suggest a genuine drug-event association requiring investigation.
  • Coincidental associations are highly improbable for rare adverse events, indicating they are not a major limitation for spontaneous reporting of such events.

Implications:

  • The findings support the continued reliance on spontaneous reporting systems for identifying potential adverse drug reactions (ADRs).
  • This statistical approach enhances the interpretation of spontaneous ADR data, particularly for rare but serious events.
  • It provides a quantitative basis for evaluating the significance of observed ADR reports in pharmacovigilance.